Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

FDA: Biowaiver on lower strengths [Regulatives / Guidelines]

posted by Yura – Belarus, 2018-05-25 12:22 (2959 d 12:16 ago) – Posting: # 18815
Views: 3,427

Hi John,
The biowaiver for lower dosages (T1, T2) is administered with the dosage (T), which participated in the bioequivalent study.
with respect

Complete thread:

FDA: Biowaiver on lower strengths jag009 2018-05-24 03:26
- FDA: Biowaiver on lower strengths wienui 2018-05-24 15:25
- FDA: Biowaiver on lower strengthsYura 2018-05-25 10:22
  - FDA: Biowaiver on lower strengths Yura 2018-05-26 17:21

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
294 visitors (0 registered, 294 guests [including 18 identified bots]).
Forum time: 00:38 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something. Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz